Fluorescent probes have been demonstrated to be promising candidates as biomarkers and biological carriers. Our study focuses on the development of a novel amphiphilic fluorescent probe with good photostability, high water solubility, excellent specificity and promising loading capability for tumor diagnosis and treatment. At first, BODIPY dye and O-carboxymethyl chitosan were prepared via a chemical reaction. Then, the prepared BODIPY dye and cRGD were bonded to O-carboxymethyl chitosan successively via an acylation reaction. Finally, we obtained the desired amphiphilic fluorescent probe: BODIPY-O-CMC-cRGD, which was based on the fluorescence resonance energy transfer (FRET) principle for selective visualization of tumors in vitro. Through a series of experiments, we found that this fluorescent probe possessed better fluorescence characteristics and tumor targeting properties.
Introduction
The unique optical properties of uorescent probes make them appealing as novel probes in biological studies 1 such as in biological imaging, biological diagnostics, biological therapy and biological carriers. Especially, over the last few decades, a large variety of uorescent probes showing photostability, 2 biocompatibility 3 and bioselectivity 4 have been developed to further advance their application in biology and medicine. A myriad of these probes, however, suffer from vital drawbacks as they have low photostability and poor water solubility.
2 Therefore, the design and development of novel uorescent probes with good photostability, excellent water solubility and high specicity are in urgent demand.
Recently, amphiphilic polymers, such as amphiphilic block copolymers 3 and hydrophobically modied water-soluble polymers, 5 have attracted extensive attention since their selfassembled nanoparticles in the aqueous media are suitable for trapping or graing hydrophobic substances 6 in biotechnology and medicine. Surprisingly, water-soluble polymers have played an increasingly important role in the construction of amphiphilic polymers; 7 especially, the chitosan polymers have been extensively used due to their unique characteristics with higher antibacterial activity, 8 more excellent biocompatibility 9 and biodegradability, 10 lower toxicity 11 and easier modica-tions. 12 The native chitosan is, however, insoluble under physiological pH conditions; this hinders its further application. Fortunately, investigators have successfully exploited various water-soluble chitosan derivatives. 13 Among the water-soluble chitosan derivatives, O-carboxymethyl chitosan (O-CMC) is an amphiprotic ether derivative that contains both -COOH groups and -NH 2 groups in the same molecule, which provide it with more favorable properties, especially with regard to water solubility.
14 For the uorophore of uorescent probes, we have chosen BODIPY, 4,4-diuoro-4-bora-3a,4a-diaza-s-indacene as it can provide sharp uorescence emissions, high uorescence quantum yields, large absorption extinction coefficients, excellent photochemical stability, narrow excitation/emission bandwidth and low sensitivity to environmental variations; 15 especially, its emission wavelengths lie in the visible range.
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The core of BODIPY dye is yet hydrophobic and does not meet the requirements of water-soluble probes. Therefore, the BOD-IPY structure should be modied to improve its hydrophilicity. It can be conjugated to the backbone of -NH 2 groups of O-CMC, and the macromolecules can exhibit preeminent solubility, stability and uorescence in aqueous systems. However, its application is further hindered in biological and medical elds due to lack of target specicity. Many targeting groups such as active targeting groups and passive targeting groups 17 have been reported several times. Therein, peptides, arginine-glycineaspartic acid, RGD, exhibit higher binding affinity to cells of the tumour neovasculature, which express a v b 3 integrin. 18 Upon graing RGD to the -COONa group of O-CMC, we obtained absolutely water-soluble uorescent probes targeting tumor cells.
We prepared a highly water-soluble and specic-targeting uorescent probe: BODIPY-O-CMC-cRGD, which showed a specic uorescence resonance energy transfer (FRET) effect on the BODIPY dye when the BODIPY donor absorbed light energy. [19] [20] [21] Further, BODIPY-O-CMC-cRGD used herein as a polymeric carrier could encapsulate two different dyes by selfassembly. Hence, two nanoparticles were prepared with BOD-IPY2 and porphyrin. The uorescent probe and the two dyes may be traced by their different uorescence spectra since the uorescence characteristics of the two dyes are different from that of the BODIPY-O-CMC-cRGD probe. In conclusion, we estimate that a novel visual diagnosis and treatment nanoparticle can be exploited if two different dyes are replaced with some antineoplastic drugs in the future.
Experimental

Materials
Tetrahydrofuran and toluene were distilled in vacuum before use. Dichloromethane and acetone were reuxed with calcium hydride for 12 h and distilled before use. Other solvents were of analytical grade and used without further purication. 4-Hydroxybenzaldehyde, ethyl 6-bromohexanoate, pyrrole, Nbromosuccinimide (NBS), 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), bis(triphenylphosphine)palladium dichloride (Pd(PPh 3 )Cl 2 ), N-hydroxysulfosuccinimide (NHS), 1-ethyl-3-(3-(dimethylaminopropyl)carbodiimide (EDCI), and chitosan (molecular weight 100-150 kDa, DA-80) were purchased from Aladdin (Beijing, China) and used without further purication. The cyclic Arg-Gly-Cys-Asp-Tyr-Lys (c(RGDyK)) peptide was purchased from Shanghai Dechi Biosciences Co. Ltd. (Shanghai, China). The semipermeable membrane (3500 Da cut-off) used for dialysis was purchased from Shanghai Yuanye Biotechnology Co. Ltd (Shanghai, China). Deionized water was used for all experiments. The U87-VIII cells were obtained from ATCC (the American Type Culture Collection, Manassas, VA, USA).
Synthesis of BODIPY dye
The BODIPY dye was synthesized via the route shown in Scheme 1. A mixture of 4-hybroxybenzaldehyde derivative and 2.2 equivalent of ethyl 6-bromohexanoate was reuxed in dry acetone for 12 h in the presence of potassium carbonate. 22 We obtained compound 1 aer purication. Compound 2 was obtained in a sequence of steps by nucleophilic reaction, brominated reaction and oxidation reaction under strict water-free and oxygen-free conditions. 23, 24 Compound 3 and compound 4 were obtained respectively by the classical Suzuki reaction 25 and traditional alkaline hydrolysis. 26 Finally, the expected BODIPY dye was obtained by amidation. 27 
Synthesis of O-CMC
O-CMC was prepared as reported previously. 28 Herein, 2 g chitosan was rst suspended in a sodium hydroxide solution (10%, w/w, 10 mL) at 60 C for 1 h. Then, 6 g monochloroacetic acid dissolved in 4 mL isopropanol was added to the abovementioned solution over 1 h and reacted for 4 h at the same temperature continuously. To this, 40 mL ethyl alcohol (70%) was added to stop the reaction. The precipitate was ltered, washed three times with ethanol (70%) and once with anhydrous alcohol, and then dried under vacuum for 6 h at 60 C.
Synthesis of BODIPY-O-CMC and BODIPY-O-CMCcRGD
In a ame ask, 10 mg O-CMC was dissolved in 10 mL deionized water, followed by the addition of some equivalent of BODIPY to DMSO. 29 The reaction was performed at 35 C for 12 h. The mixture was dialyzed for 48 h to remove the excess reactants.
The nal product BODIPY-O-CMC obtained was lyophilized.
For BODIPY-O-CMC-cRGD synthesis, 20 mg BODIPY-O-CMC, 3 mg EDCI and 2 mg NHS were dissolved in 20 mL PBS, pH ¼ 6.86. The reaction was conducted at room temperature for 12 h, and then, 6 mg cRGD peptide was added. 30 Aer 24 h, the resultant solution was dialyzed against water (3500 Da cut-off) for 3 days, followed by lyophilization to produce the desired uorescent probe: BODIPY-O-CMC-cRGD.
Preparation of the dye-loaded nanoparticles BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin by the thin-lm dispersion method
The preparation of dye-loaded polymer nanoparticles had already been described in the literature.
31-33 BODIPY2 34 was synthesized by our research group. For this, 5 mg BODIPY2 was rst dissolved in 5 mL anhydrous methanol in a 25 mL roundbottomed ask. Then, the solution was added to an appropriate amount of BODIPY-O-CMC-cRGD, and the suspension was kept in an ultrasonic water bath for 3 h; some mixed membranes remained at the bottom of the ask aer removing methanol by evaporation in a water bath at 45 C. The membranes was dissolved in 4 mL deionized water and then mixed with ultrasonic probes for 5 min (200 W, work 2 s, halt 2 s). Then, the crude nanoparticle solution was passed through a lter (0.45 mm) to remove unreacted BODIPY2. The ltrate thus obtained contained the nanoparticles, which were abbreviated as BODIPY-O-CMC-cRGD/BODIPY2. Porphyrin
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-loaded uorescent probe nanoparticles, BODIPY-O-CMC-cRGD/ porphyrin, were prepared using the same method. The uorescence images of the stained U87-VIII cells were obtained by CLSM using an argon laser. The maximum excitation wavelengths for BODIPY dye, BODIPY 2, and porphyrin were 561, 488, and 594 nm, respectively, and the corresponding emission wavelengths for the three samples were 615, 514, and 670 nm. The maximum excitation and emission wavelengths for DAPI were 360 and 488 nm, respectively.
Cytotoxicity of BODIPY-O-CMC-cRGD, BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin
To examine the toxicity of BODIPY-O-CMC-cRGD, BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin in living cells, U87-VIII cells were seeded in 96-well plates with a density of 10 5 cells in every well and incubated in DMEM with samples for 48 hours. Aer incubation, the medium was removed, and the cells were washed with PBS three times. The medium of the plates was replaced by MTT followed by incubation at 37 C under an atmosphere of 5% CO 2 for 4 h. The medium was removed followed by the addition of 150 mL of DMSO. The absorbance wavelength was set at 560 nm to measure the results using a microplate reader.
Results and discussion
3.1 Analysis of the FTIR spectrum and 1 H-NMR spectrum À groups and -NH 2 groups in the same molecule. Fig. 1(B) shows the FTIR spectra of O-CMC. The band assignment of O-CMC was as follows (cm À1 Fig. 1(D) shows that the peak at 1074 cm À1 enhances signicantly due to the -C-O stretching and bending vibration of cRGD; Fig. 2 (D) shows the peculiar signals at 7.09 and 6.80 ppm, which are attributed to the aromatic protons of cRGD. The results indicated that cRGD was attached to BODIPY-O-CMC. In addition, this conclusion was proven by confocal experiments. The degrees of substitution by BODIPY dye and cRGD groups, calculated from the content of elements B, F, S and C of the XPS (in Fig. 3 ), were 2.75% and 3.26%, respectively.
Analysis of UV-vis absorption and uorescence spectra
The BODIPY dye was synthesized as a highly uorescent diaryl derivative carrying aryl groups at the 3-and 5-positions of the core skeleton. Herein, 4-hydroxybenzaldehyde reacted with ethyl 6-bromohexanoate to afford a long-chain fatty acid ester, which was easily conjugated with the -NH 2 group of O-CMC.
Aer the Suzuki reaction of compound 2 and arylboronic acid, compound 3 was found to have a longer wavelength when compared with the precursor intermediates. We investigated the absorption and emission spectra of the ultimate BODIPY dye in CH 2 Cl 2 at different concentrations. As shown in Fig. 4(A) , the absorption spectra of the BODIPY dye contained narrow spectral bands with two absorption peaks in the visible region.
The intense band at 560 nm was attributed to the central skeleton of BODIPY and the pronounced shoulder on the highenergy side of the main band resulted from the ve-membered ring containing nitrogen. Fig. 4(B) shows that the BODIPY derivative in CH 2 Cl 2 has an emission spectrum with a maximum at 615 nm. These results indicated that the BODIPY dye had a Stokes shi of 55 nm. Fig. 4(C and D) show the UV and uorescence spectra of BODIPY-O-CMC for more accurate conjugated evaluation. The spectra shown in Fig. 4(A-D) had signals of BODIPY. 
H-NMR spectra of (A) CMC (B) O-CMC (C) BODIPY-O-CMC and (D) BODIPY-O-CMC-CRGD.
Dye-loaded polymeric nanoparticles were prepared by selfassembly with the uorescent probe BODIPY-O-CMC-cRGD and two other dyes of different structures, namely BODIPY2 and porphyrin. BODIPY-O-CMC-cRGD had strong amphiphilic property owing to the presence of both hydrophobic BODIPY graed onto moieties and hydrophilic cyclic peptide graed onto the carboxyl group of O-CMC. In this study, two water-insoluble dyes were encapsulated into the uorescent probe by hydrophobic interactions. Obviously, the two nanoparticles had good solubility in water, as observed from the Fig. 5 , and were characterized by UV and uorescence spectra. In an aqueous solution, as depicted in the UV-Vis absorption spectra shown in Fig. 4(E) , the BODIPY-O-CMC-cRGD/ BODIPY2 nanoparticles exhibited a prominent broad peak at 475-540 nm probably due to the overlap UV-Vis absorption of BODIPY dye and BODIPY2 of the consequences of colloidal solution. We would continue to verify the mechanism in our future work. Correspondingly, in the uorescence spectra in Fig. 4(F) , the BODIPY-O-CMC-cRGD/BODIPY2 nanoparticles manifested two optimal emission bands at 514 nm of BOD-IPY2 and 615 nm of BODIPY dye when excited at 480 nm. Analogously, the absorption spectra and uorescence spectra of BODIPY dye and porphyrin of BODIPY-O-CMC-cRGD/ porphyrin nanoparticles similar to that of pure BODIPY dye and porphyrin could be discriminated distinctly in Fig. 4(G  and H) , respectively. The results indicated that the two dyes were successfully loaded into the BODIPY-O-CMC-cRGD nanoparticles.
Analysis of SEM and optical microscopy images
The surface morphologies of BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin were examined by optical microscopy and SEM, as shown in Fig. 6 . The optical microscopy image showed that the self-assembled particles were almost spherical in shape. In SEM images, the two nanoparticles presented irregular shapes. The size of BODIPY-O-CMC-cRGD/porphyrin nanoparticles was bigger than that of BODIPY-O-CMC-cRGD/BODIPY2; this was because the structure of porphyrin was rigid, whereas the structure of BODIPY2 was exible. The SEM images coincided with those of the optical microscope.
Analysis of particle size
The particle sizes and zeta potential of BODIPY-O-CMC, BOD-IPY-O-CMC-cRGD, BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin were measured. From Table  1 , it can be noted that they have unimodal particle size distribution, and particle sizes increase because the hydrophobic dye has been inserted into BODIPY-O-CMC. The sizes of porphyrin were larger than those of BODIPY2, and the particle size provided evidence supporting the results of SEM.
Cytotoxicity assay
Fluorescent materials as biological probes require low toxicity. Thus, the cytotoxicity of BODIPY-O-CMC-cRGD, BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin was measured by the MTT assay in U87-VIII cells. The viability The intracellular localization of BODIPY-O-CMC, BODIPY-O-CMC-cRGD, BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin nanoparticles that were taken up by the cells via the endocytic pathway was visually traced by confocal laser scanning microscopy (CLSM). Fig. 8 showed that all the uorescent materials exhibited strong and stable uorescence signals via CLSM. Although the specicity of cRGD had already been reported, 18 the images presented in Fig. 8(A and B) did not reveal apparent specicity. The reason could be that BODIPY-O-CMC and BODIPY-O-CMC-cRGD possessed similar particle sizes and electronegativities, whose effects were more favorable to cell endocytosis than to cell affinity of cRGD. Fig. 8(C-E) showed that the nanoparticles of BODIPY-O-CMC-cRGD/BODIPY2 were endocytosed into the cells. These results demonstrated that the uorescent probe BODIPY-O-CMC-cRGD was an efficiently targeted delivery vector for tumor cells, and it could take pure BODIPY derivatives into tumour cells. By further comprehensive comparison of Fig. 8(C, D, and E) , all released processes were distinctly observed. Fig. 8(C) showed that only few nanoparticles were taken up by the tumor cells aer 4 h of incubation, and BODIPY2 still remained encapsulated in BODIPY-O-CMCcRGD. Fig. 8(D) showed that more nanoparticles were endocytosed into tumor cells, but part of BODIPY2 was released from the nanoparticles aer 8 h of incubation. Moreover, BODIPY2 remained in the cells, and BODIPY-O-CMC-cRGD was far away from tumor cells. Fig. 8 (E) showed that many nanoparticles had entered the cells, and more BODIPY2 was discharged from the nanoparticles. Simultaneously, BODIPY2 accumulated in the cells. Hence, from Fig.  7(C-E) , it could be observed that the BODIPY-O-CMC-cRGD/ BODIPY2 nanoparticles possessed prominent biocompatibility and were released in a slowly dynamic process from the tumor cells. The nanoparticles were endocytosed into tumor cells, and the uorescence of BODIPY dye, which was the internal segment of BODIPY-O-CMC-cRGD, and BODIPY2, which was encapsulated in BODIPY-O-CMC-cRGD, changed from the state of overlapping to separation aer a period of time. This indicated that BODIPY2 diffused into tumor cells. Fig. 8(F-H) showed that there were no BODIPY-O-CMC-cRGD/ porphyrin nanoparticles inside the cell aer 4 h, 8 h, and 12 h of incubation. It turns out that the structure of porphyrin was rigid, leading to an inexible framework of BODIPY-O-CMCcRGD/porphyrin nanoparticles, which was against the tumor cell endocytosis, whereas the structure of BODIPY2 was ex-ible. Based on all the abovementioned results, we could depict the prospects that a novel uorescent probe, BODIPY-O-CMCcRGD, loaded with exible structures of antineoplastic drugs replacing dyes would be a promising candidate as a visualized and targeted delivery vehicle facilitating more accurate tumor diagnosis and therapy in clinical applications. We predict that this study will revolutionize the conventional medical practices in the coming decades.
Conclusions
In this study, we have successfully prepared a uorescent probe, BODIPY-O-CMC-cRGD, based on the FRET principle as a tumor cell tracer and an excellent delivery vehicle. The BODIPY dye-conjugated O-CMC had good photostability, and the BODIPY dye's uorescence emission wavelength basically remained unchanged. The results of UV absorption spectra, uorescence emission spectra, FTIR spectra, 1 H-NMR spectra and SEM illustrated that BODIPY-O-CMC-cRGD, BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin were prepared successfully. The cytotoxicity assay made clear that BODIPY-O-CMC-cRGD had low toxicity. Confocal laser scanning microscopic analysis proved our successful fabrication of the two nanoparticles BODIPY-O-CMC-cRGD/BODIPY2 and BODIPY-O-CMC-cRGD/porphyrin with target specicity and dye release for tumor cell imaging. It can be envisioned that the proposed uorescent probe BODIPY-O-CMC-cRGD may be used in targeted imaging and diagnosis. Furthermore, we consider that it has potential as a drug delivery vehicle, and we may prepare a novel drug integrated with visualized diagnoses and therapies in the future by replacing dyes with some antineoplastic drugs. In other words, we preconceive that the therapeutic agents will foster the development of theranostic nanoparticles with integrated targeted probe diagnosis and visualized drug therapy.
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